CELESTE RICHARDSON: Open Payments
NPI 1801245352 · TRUSSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,809 in 168 payments from 25 companies in 2025. Trend: 2023 $2,696 · 2024 $2,831 · 2025 $2,809
Food & beverage: $2,809
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 23 | $328 |
| Novo Nordisk Inc | 19 | $238 |
| GlaxoSmithKline, LLC. | 10 | $236 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $220 |
| Amgen Inc. | 15 | $214 |
| Sumitomo Pharma America, Inc. | 11 | $204 |
| ABBVIE INC. | 15 | $190 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $158 |
| AstraZeneca Pharmaceuticals LP | 8 | $152 |
| Lilly USA, LLC | 9 | $145 |
Products named: NURTEC ODT, TRELEGY ELLIPTA, CAPLYTA, GEMTESA, Kerendia, JARDIANCE, TRINTELLIX, Veozah.
Industry payments across AL — which companies pay providers there.
